Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis (Q38112273)

29 August 2017

title

Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis (English)

1 reference

29 August 2017

1 reference

Derick Okwan-Duodu

1

1 reference

29 August 2017

Jerome Landry

series ordinal

2

1 reference

29 August 2017

Xiao Z Shen

series ordinal

3

1 reference

29 August 2017

Roberto Diaz

series ordinal

4

1 reference

29 August 2017

language of work or name

1 reference

5 June 2013

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

29 August 2017

published in

1 reference

29 August 2017

volume

305

1 reference

29 August 2017

issue

3

1 reference

29 August 2017

page(s)

R205-15

1 reference

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Synthesis and effects of active fragments of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

CD14CD16 monocyte subset levels in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Human embryonic stem cells hemangioblast express HLA-antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Views of the renin-angiotensin system: brilling, mimsy, and slithy tove

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Extracellular aspartic protease SAP2 of Candida albicans yeast cleaves human kininogens and releases proinflammatory peptides, Met-Lys-bradykinin and des-Arg(9)-Met-Lys-bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Targeting regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensinogen and its cleaved derivatives inhibit angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Origins of tumor-associated macrophages and neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

18 Peptidyl dipeptidase A: Angiotensin I-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

T-regulatory cells: key players in tumor immune escape and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: substance P role in peripheral inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Induction of angiotensin converting enzyme in human monocytes in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The renin-angiotensin system and cancer: old dog, new tricks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Regulation of T-cell function by endogenously produced angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Activation of bradykinin B1 receptor by ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin II type 1 receptor (AT-1R) expression correlates with VEGF-A and VEGF-D expression in invasive ductal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Clinical translation of angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin-converting enzyme is required for normal myelopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin beta4 in neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Evidence for involvement of ROCK signaling in bradykinin-induced increase in murine blood-tumor barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Bradykinin promotes the chemotactic invasion of primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

NK-1 as a melanoma target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The NK-1 receptor: a new target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin-converting Enzyme Overexpression in Mouse Myelomonocytic Cells Augments Resistance to Listeria and Methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Increased angiotensin II-induced hypertension and inflammatory cytokines in mice lacking angiotensin-converting enzyme N domain activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Tachykinins and their receptors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Hematopoietic regulation mediated by interactions among the neurokinins and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiogenesis and G-protein-coupled receptors: signals that bridge the gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The plasma kallikrein-kinin system counterbalances the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The carboxypeptidase ACE shapes the MHC class I peptide repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Nontraditional roles of angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

AT1 receptor-mediated angiotensin II activation and chemotaxis of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The potential and limitations of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Bradykinin Antagonists as Anti-Cancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Embryonic origin of human hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Neurokinin 1 receptor isoforms and the control of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The renin-angiotensin system in the breast and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Angiotensin-I converting enzyme inhibitors suppress angiogenesis and growth of esophageal carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Cigarette smoke synergizes lipopolysaccharide-induced interleukin-1β and tumor necrosis factor-α secretion from macrophages via substance P-mediated nuclear factor-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Mice Lacking Endothelial ACE

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00544.2012

10.1152/AJPREGU.00544.2012

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference